Reports
Reports
Sale
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Electrophoresis Equipment Market Overview
3.1 Global Electrophoresis Equipment Market Historical Value (2017-2023)
3.2 Global Electrophoresis Equipment Market Forecast Value (2024-2032)
4 Global Electrophoresis Equipment Market Landscape*
4.1 Global Cardiac Pacemaker: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Cardiac Pacemaker: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Application
4.2.3 Analysis by End User
5 Global Electrophoresis Equipment Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Electrophoresis Equipment Market Segmentation (2017-2032)
6.1 Global Electrophoresis Equipment Market (2017-2032) by Products
6.1.1 Market Overview
6.1.2 Electrophoresis Reagents
6.1.3 Electrophoresis Systems
6.1.4 Gel Documentation Systems
6.1.5 Electrophoresis Software
6.2 Global Electrophoresis Equipment Market (2017-2032) by Application
6.2.1 Market Overview
6.2.2 Diagnostic Application
6.2.3 Research Application
6.2.4 Quality Control & Process Validation
6.3 Global Electrophoresis Equipment Market (2017-2032) by End User
6.3.1 Market Overview
6.3.2 Hospital & Diagnostic Centers
6.3.3 Pharmaceutical & Biotechnology Companies
6.3.4 Academic & Research Institutes
6.3.5 Others
6.4 Global Electrophoresis Equipment Market (2017-2032) by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Cardiac Pacemaker Market (2017-2032)
7.1 North America Cardiac Pacemaker Market (2017-2032) by Products
7.1.1 Market Overview
7.1.2 Electrophoresis Reagents
7.1.3 Electrophoresis Systems
7.1.4 Gel Documentation Systems
7.1.5 Electrophoresis Software
7.2 North America Cardiac Pacemaker Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Diagnostic Application
7.2.3 Research Application
7.2.4 Quality Control & Process Validation
7.3 North America Cardiac Pacemaker Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Cardiac Pacemaker Market (2017-2032)
8.1 Europe Cardiac Pacemaker Market (2017-2032) by Products
8.1.1 Market Overview
8.1.2 Electrophoresis Reagents
8.1.3 Electrophoresis Systems
8.1.4 Gel Documentation Systems
8.1.5 Electrophoresis Software
8.2 Europe Cardiac Pacemaker Market (2017-2032) by Applications
8.2.1 Market Overview
8.2.2 Diagnostic Application
8.2.3 Research Application
8.2.4 Quality Control & Process Validation
8.3 Europe Cardiac Pacemaker Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Quality Control & Process Validation
9 Asia Pacific Cardiac Pacemaker Market (2017-2032)
9.1 Asia Pacific Cardiac Pacemaker Market (2017-2032) by Products
9.1.1 Market Overview
9.1.2 Electrophoresis Reagents
9.1.3 Electrophoresis Systems
9.1.4 Gel Documentation Systems
9.1.5 Electrophoresis Software
9.2 Asia Pacific Cardiac Pacemaker Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Diagnostic Application
9.2.3 Research Application
9.2.4 Quality Control & Process Validation
9.3 Asia Pacific Cardiac Pacemaker Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Quality Control & Process Validation
10 Latin America Cardiac Pacemaker Market (2017-2032)
10.1 Latin America Cardiac Pacemaker Market (2017-2032) by Products
10.1.1 Market Overview
10.1.2 Electrophoresis Reagents
10.1.3 Electrophoresis Systems
10.1.4 Gel Documentation Systems
10.1.5 Electrophoresis Software
10.2 Latin America Cardiac Pacemaker Market (2017-2032) by Applications
10.2.1 Market Overview
10.2.2 Diagnostic Application
10.2.3 Research Application
10.2.4 Quality Control & Process Validation
10.3 Latin America Cardiac Pacemaker Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Quality Control & Process Validation
11 Middle East and Africa Cardiac Pacemaker Market (2017-2032)
11.1 Middle East and Africa Cardiac Pacemaker Market (2017-2032) by Products
11.1.1 Market Overview
11.1.2 Electrophoresis Reagents
11.1.3 Electrophoresis Systems
11.1.4 Gel Documentation Systems
11.1.5 Electrophoresis Software
11.2 Middle East and Africa Cardiac Pacemaker Market (2017-2032) by Application
11.2.1 Market Overview
11.2.2 Diagnostic Application
11.2.3 Research Application
11.2.4 Quality Control & Process Validation
11.3 Middle East and Africa Cardiac Pacemaker Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Quality Control & Process Validation
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Quality Control & Process Validation
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Thermo Fisher Scientific
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Bio-RAD Laboratories
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Merck Group
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Agilent Technologies
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Danaher Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 QIAGEN
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Harvard Apparatus
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Lonza Group Ltd.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Perkin Elmer
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Shimadzu Corporation
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Biocompare
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Thistle Scientific
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
List not exhaustive!
18 Global Electrophoresis Equipment Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
The market attained a value of about USD 3.2 billion in 2023 driven by intensive research and development activities in the medical sector across the globe.
The market is anticipated to grow at a CAGR of 5.70% during the forecast period of 2024-2032, likely to reach a market value of USD 5.27 billion by 2032.
Technological advancements in electrophoresis systems and the increased healthcare expenditure are fuelling the demand for electrophoresis equipment. Rising investment by the biotechnology and pharmaceutical companies is another factor contributing to the demand.
One of the significant trends in the market is the advent of new and innovative products to provide enhanced solutions. In February 2024, Invitrogen, a brand operated by Thermo Fisher Scientific, revealed its fully integrated E-Gel™ Power Snap Plus Electrophoresis System. The single platform has the capability to run, visualize, and image mutiple DNA samples per run.
Based on the product, the market is segmented into electrophoresis reagents, electrophoresis systems, gel documentation systems, and electrophoresis software.
Major end users of electrophoresis equipment include hospital and diagnostic centers, pharmaceutical and biotechnology companies, academic as well as research institutes, among others.
Application areas of electrophoresis equipment include diagnostic applications, research applications, quality control, and process validation.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
Key players involved in the market are Thermo Fisher Scientific, Bio-RAD Laboratories, Merck Group, Agilent Technologies, Danaher Corporation, QIAGEN, Harvard Apparatus, Lonza Group Ltd., Perkin Elmer, Shimadzu Corporation, Biocompare, and Thistle Scientific.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.